Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EPOPROSTENOL Cause Drug delivery system malfunction? 57 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 57 reports of Drug delivery system malfunction have been filed in association with EPOPROSTENOL (EPOPROSTENOL). This represents 0.4% of all adverse event reports for EPOPROSTENOL.

57
Reports of Drug delivery system malfunction with EPOPROSTENOL
0.4%
of all EPOPROSTENOL reports
1
Deaths
51
Hospitalizations

How Dangerous Is Drug delivery system malfunction From EPOPROSTENOL?

Of the 57 reports, 1 (1.8%) resulted in death, 51 (89.5%) required hospitalization.

Is Drug delivery system malfunction Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EPOPROSTENOL. However, 57 reports have been filed with the FAERS database.

What Other Side Effects Does EPOPROSTENOL Cause?

Dyspnoea (2,744) Headache (2,425) Diarrhoea (2,310) Nausea (2,016) Pain in jaw (1,928) Death (1,362) Flushing (1,256) Fatigue (1,133) Hospitalisation (1,078) Vomiting (1,068)

What Other Drugs Cause Drug delivery system malfunction?

GUSELKUMAB (686) GOLIMUMAB (406) PEGINTERFERON BETA-1A (367) TOCILIZUMAB (263) EXENATIDE (243) USTEKINUMAB (194) PEGFILGRASTIM (187) INTERFERON BETA-1A (185) ALBUTEROL (142) BUDESONIDE\FORMOTEROL (115)

Which EPOPROSTENOL Alternatives Have Lower Drug delivery system malfunction Risk?

EPOPROSTENOL vs EPTIFIBATIDE EPOPROSTENOL vs EPTINEZUMAB-JJMR EPOPROSTENOL vs EPTINEZUMAB\EPTINEZUMAB-JJMR EPOPROSTENOL vs EQUINE BOTULINUM NEUROTOXIN A/B/C/D/E/F/G IMMUNE FAB2 EPOPROSTENOL vs EQUINE THYMOCYTE IMMUNE GLOBULIN

Related Pages

EPOPROSTENOL Full Profile All Drug delivery system malfunction Reports All Drugs Causing Drug delivery system malfunction EPOPROSTENOL Demographics